ROCKVILLE, Md.--(BUSINESS WIRE)--20/20 BioResponse, a business unit of 20/20 GeneSystems, Inc. announced today that it will begin shipping its CoronaCheck ™ COVID-19 Rapid Antibody Test Kit. The ...
Public perception of cancer risk. This is an ASCO Meeting Abstract from the 2012 ASCO Annual Meeting I. This abstract does not include a full text component.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results